Fundraising Fox

Keith A. Goldan

Chief Financial Officer at Syndax Pharmaceuticals

Downingtown, Pennsylvania, United States

Find your path to Keith

Chief Financial Officer at Syndax Pharmaceuticals

Intro paths

→

In turn, Keith can intro founders to Syndax Pharmaceuticals's investors below.

Syndax Pharmaceuticals's investors · 7

BlackRockWilmingtonDomain AssociatesPrinceton · $200K – $15M checksForesite CapitalWest HollywoodMPM BioImpactBoston · $1M – $15M checksPappas CapitalDurhamSofinnova VenturesMenlo Park · $100K – $15M checksvenBio PartnersSan Francisco

Experience

  1. Syndax PharmaceuticalsChief Financial Officercurrent2022 — present
  2. Abeona TherapeuticsBoard Membercurrent2026 — present
  3. Driven Strength and FitnessCo-founder and Ownercurrent2017 — presentExton, Pennsylvania, United States
  4. Downingtown STEM AcademyAdvisory Board Member2015 — 2025Downingtown, PA
  5. OptinoseChief Financial Officer2017 — 2022Yardley, PA
  6. FibrocellSenior Vice President & CFO2015 — 2017Exton, PA
  7. NuPathe Inc.Senior Vice President & CFO2008 — 2014
  8. PuriCoreCFO and Board Member2004 — 2008
  9. BiosynV.P. and CFO2001 — 2004
  10. ViroPharma IncorporatedDirector of Strategic Analysis1997 — 2001Exton, PA
  11. KPMGAssociate1993 — 1997Princeton, NJ

Skills & more

Pharmaceutical Industry15Mergers & Acquisitions55Corporate Development41Investor Relations22Strategic Planning27IPO13Start-ups34Mergers9Financial Reporting9Executive Management23Financial Analysis6Private Equity10
+8 moreFinanceBusiness DevelopmentBusiness PlanningStrategic Financial PlanningCapital RaisingBusiness StrategyAcquisitionsBiotechnology

From Keith's professional profile.

Frequently asked questions

Who is Keith A. Goldan?
Chief Financial Officer at Syndax Pharmaceuticals
Where does Keith A. Goldan work?
Keith A. Goldan is Chief Financial Officer at Syndax Pharmaceuticals.
Where did Keith A. Goldan go to school?
Keith A. Goldan studied at The Wharton School (MBA); University of Maryland (BS, Finance); Hillsborough High School.

Same school

Also attended The Wharton School2,000

Sarah GuoFounder & General Partner of ConvictionJosh KopelmanFounder and Partner at First Round CapitalAydin SenkutFounder & Managing Partner at FelicisJack AbrahamFounder, CEO & Managing Partner of AtomicKatie RiesterPartner, Head of Investor Relations at Felicis VenturesTrevor OelschigInvestment Team at General Catalyst

+ 1,994 more

Also attended University of Maryland403

Katrina PagliaChief Legal Officer at Pantera CapitalSujal PatelStrategic Director at Madrona Venture GroupDaniel DemmerInvestor at OpenView Venture PartnersDan RochkindCFO at Lerer HippeauAaron EpsteinGeneral Partner at Y CombinatorKevin NiechenInvestment Team at 8VC

+ 397 more

Also attended Hillsborough High School3

Alan LiuCEO/Founder at Health HarborShloke PatelFounder at Human ArchiveVarun KandulaFounder at Kinect

Shared employers

Also worked at Syndax Pharmaceuticals5

Briggs MorrisonEntrepreneur Partner at MPM BioImpactSteven FruchtmanExecutive Officer at Onconova TherapeuticsArlene MorrisExecutive Officer, Director at Syndax PharmaceuticalsJOANNA HOROBINExecutive Officer at VerastemMichael A. MetzgerChief Executive Officer at Syndax Pharmaceuticals

Also worked at Abeona Therapeutics3

Stefano BuonoFounder at Elysia CapitalTimothy J. MillerExecutive Officer, Director at Forge BiologicsMichael AmorosoPresident, Chief Executive Officer at Precision BioSciences

Also worked at Optinose3

Kyle DempseyPartner at MVM Life Science PartnersLeanne KellyExecutive Officer at GRI BIOBogdan ButoiCo-founder & CEO at Merlin Mobility

Also worked at ViroPharma Incorporated1

Jeffrey M. Dayno, M.D.President and Chief Executive Officer at Harmony Biosciences